Why Moderna Tanked, MSG Employees Duped By Their Boss, The Mansion Section | Diet TBPN
23 Oct 2026 · 33 min
In this episode of the Diet TBPN podcast, hosts John Coogan and Jordi Hays, joined by producer Tyler and occasional guests, weave together a rapid‑fire mix of tech, finance, and pop‑culture news. They start with the release of Call of Duty: Modern Warfare 4 and a daily Christmas countdown, then dive deep into Moderna’s mRNA cancer‑vaccine trial: the company’s phase‑3 data leaked early, showing a 42% relative risk reduction (down from the previously‑cited 49%), which triggered a 26% intraday stock plunge. The hosts recount how fitness‑and‑gambling influencer Shane “Togi” Stouffer timed a massive options flip just before the crash, turning a potential loss into a windfall. The conversation shifts to a bizarre MSG employee‑ring phishing test that tricked Knicks staff, prompting a discussion of corporate cybersecurity tactics. They then cover a recent Quest Diagnostics data breach, noting the exposure of patient records and potential extortion motives. The panel jokes about using AI‑driven “Grok/TradBot” for parenting advice, highlighting Joe Lonsdale’s contrarian use of the tool. A brief “Mansion” segment spotlights a 147‑acre Alaskan estate listed for $12.5 million, complete with a helipad and family‑friendly amenities. Finally, they explore speculative bio‑engineering projects from Palmer Luckey and Ben Lamb, including genetically‑engineered dogs and even giant, laser‑armed sharks for military use. Throughout, the tone remains conversational, humorous, and occasionally critical, with frequent asides, jokes, and listener‑style banter.
Chapters
Big news: Call of Duty Modern Warfare 4 multiplayer dropped today. Tyler is going to try and prestige while we're doing the show, so he's locked in. Don't count on him to look anything up for us because he is trying to go on a kill streak right now. Let me tell you about Ramp. Time is money. Save both. Easy to use corporate cards. Bill, you know we started this show with like. Let's just get right into the show. And the whole bit was like, we'd just be like Technology Brothers, and then we'd just start the show, and it was like really convenient. And now we're like, we got to tell you about RAMP, we got to tell you about the UltraDome, we got to tell you about the Road to Christmas, we got to tell you about COD. But the Road to Christmas, how many days are there to Christmas? Because that's why you come to the show. You want to know how many days there are until Christmas. Let's count it down. 62 days until Christmas.
There you go.
Jeff Bezos is also 62 years old. What is that? We got fun facts now. This is elite. Good job, production team. I like that. We're going to learn about a different number every day, I guess, on the way down. Oh, this is very cool. I like that.
Well, very, very cool.
Let's try and give you some news while we— while Tyler tries to—
please, sir. Just a bit of news.
Just a bit of news. So Moderna. Moderna is in the Wall Street Journal today. And it's an interesting story. Data from Moderna's cancer therapy leaked and the stock has been on this wild ride up and down, fueled by speculation that they cured cancer. They said the AI labs, they've been talking a big game. Nobody's doing it without us doing it first.
I would hate for an AI lab to cure cancer before we do.
That's exactly what they said. And they actually did have some really promising results. But it's a very fascinating story because obviously curing cancer is a very broad term. Insane that the AI lab leaders try and collapse it down to just like it's going to be done. Clearly, it's like a game of cat and mouse with all these things. Like there's always some level of cancer in your body that your body's naturally fighting off. And then there's really bad cancer that not— no one can solve because it's metastasized so significantly. And then there's much more modern, much more moderate forms that if you catch them on time, you can fight back with both surgery, just removing the cancerous cells, the tumors, also drug treatments. There's a bunch of great cancer drugs that are out there. Some of them are blockbusters like Keytruda from Merck, which was actually used in concert with Moderna. So Moderna didn't say, this is going to be used by itself. They said, we'll be using this in concert with Keytruda. And so basically, this has been Moderna's core idea for the company going back to 2013. Stephane Bancel, the CEO, I don't know if he's the co-founder CEO, but he did a TED Talk in 2013 where he said like, We are gonna be able to design patient-specific drugs for cancer. And he was standing on stage being like, guys, we're gonna cure cancer. And everyone's like clapping at Ted. And then 3 years later, they were calling him the Theranos because they were like, this is not gonna happen. This is completely fake. Your company's really secretive. And then he started delivering, but it took a really long time. And the company was really secretive and would require people to sign NDAs to come in the building. And all of that. all of that was sort of like offset by the fact that they continued to deliver. And they actually did get up through a successful phase 3 trial with this particular drug. So it's not a one-shot solution. Of course, like curing cancer is this broad spectrum. And so the way it works is that scientists sequence a patient's tumor, identify mutations unique to their specific cancer, and then manufacture an mRNA vaccine that teaches the immune system to recognize and attack those cancer cells. The treatment is actually administered alongside Merck's Keytruda, which I mentioned, an existing cancer immunotherapy drug. And the hope is that the combination can prevent cancer from returning after surgery and eventually work against many different types of cancer. So the early results, the early results that they had sort of gestured towards in the phase 2 was a 49% reduction in relative risk of cancer recurrence or death compared to Keytruda alone. So you're on the best in class, 'cause even when they do these studies, they're not just gonna say, hey, we want you to go cold turkey, we want you to go completely vanilla.
Yeah.
say, you can use the drugs that are already available. Will this be better than just the drugs that are available currently? So they had this 49% number, and that's the important number to anchor on because phase 3 was going to tell you, was it higher than 49% when they did more trials, or was it lower? And spoiler alert, of course, it came in lower. That's why there's all the drama. But in August of 2016, Moderna announced that its much larger phase 3 trial, which had 1,137 patients, over 1,000 cancer patients went through this trial doing Keytruda and the Moderna treatment. They said our phase 3 trial succeeded, succeeded, but they didn't say the data behind it. They didn't say the number. They didn't update that 49%.
No.
So everyone was like, this is incredible. They cured cancer. The stock moons. But on October 2nd, the detailed results leaked, which is crazy. because they were basically embargoed and it was 2 days before Moderna was scheduled to present them. And in biotech, these presentations about the actual results are very precisely traded by hedge funds. It matters a lot.
Yeah.
And so they like, you shouldn't leak them, but a medical publication called Oncology Central apparently published an article containing the embargoed clinical data ahead of schedule. Screenshots circulated on X and Moderna stock plunged 26% intraday, eventually closing down 18%. And it's not that they secretly failed the trial. It's not that they said they succeeded it and then the data came out and they failed. What actually happened was that the phase 3 did succeed, but the results weren't as spectacular as investors had hoped. Instead of the 49% that I mentioned before, it was only 42%, which is still pretty good, but it wasn't good enough. It's great if you're a cancer patient, but it's not so good if you're an investor who's banking on 49% or maybe a beat, maybe an update.
Yeah.
Hey, it's actually better than than we expected. And so you can kind of understand how the market would react to that. Also, the phase 3 trial showed that Moderna's treatment really only starts to be effective after 6 months. It starts kicking in. So if you have a really aggressive, fast-growing cancer, it doesn't really help all that much. It's more for someone who has like a slow-burn cancer that's sort of, they're fighting it off over the course of a year or 2. That's when Moderna is going to help. And so—
Somewhat disappointing results.
Relative to the expectations, right? Just didn't meet expectations. Not a beat in the clean sense. And so that's all just a normal biotech story. But then it takes a bizarre turn because a fitness and gambling influencer, which is how he's described, named Shane Stouffer, who's better known as Togi, Managed to time Moderna's crash almost perfectly.
Nothing, nothing.
Flipping his entire position from calls to puts just hours before it plunged. And so we have some more information on Togi, and I don't know if we have any videos that we want to pull up to contextualize for the audience who Togi is, because he's a true character in the modern online world. Do you have any—
I don't know if you could pull up just any video.
I don't think we could. It's kind of dangerous. He's a, he's a real wild card.
I sent in a video that I think is Okay.
Oh, it's context for him. Okay, we'll play that video. And while we're pulling it up, give me the update on how you did in your first game of Call of Duty Modern Warfare.
I went 13 and 14. Not great.
13 and 14.
But you know, first game, just getting the feeling.
Okay. Okay.
I'm feeling confident though.
Oh yeah.
Oh yeah. First time on this map.
Can we get a camera on Jackson? Yeah, we need a camera on Jackson ASAP. He put together the fit of all fits of the month. Fit of the month. And it's only spin it around. Where are we? Here we are.
Here we go.
All right, zoom out a little bit.
There we go.
Okay, what do you got on, Jackson?
I got the front Dale and the back Dale.
What's on the feet? Do we got boots on the feet? Okay, what do we got?
Um, happy to be here.
There we go.
Fantastic.
Looking great. Looking great. Thank you for that.
So do we have that togy video to contextualize for everyone? Can we Pull that up. Okay, this is Togi, the fitness and gambling influencer.
Like every day, I probably have like six like useful thoughts, and then the rest of it's just kind of like.
Give me an example of a useful thought you had today.
Oh no, today was bad.
What an entertainer! Anyway, on October fourth, Togi, the man pictured in that video. Was trying to speed up his stock video trading challenge, which is already a hilarious premise. He said he noticed people online acting bearish towards Moderna. Everyone was turbo bullish on every stock except one, dollar sign MRNA. Everyone and their mother could only talk about how overvalued it was and how good of a short it was. Then he decided to go against the crowd and bought Moderna calls. That night, he had a dream that Moderna cured cancer and the stock. went to $275. It's trading around $200 today. It was at almost $250 a little bit earlier, making his portfolio, if these calls had hit, worth $11 million. This was his dream. After the dream, he asked Claude what it would take for Moderna to actually reach $275. That's when he said he learned about Moderna's cancer vaccine. Wait, for the first time, he just has this dream based on, Vibes-based analysis. He's vibes trading. Over the next 2 weeks, the stock went up 25%. And Togi got worried that all the hype from the trial was already priced in. Then he had another dream. There we go. This time, that Moderna stock would surge 22%. I thought— this is a quote from him. He says, I thought it was a sign from God that I was wrong about the top being in and that I should trust my original swap end of market on Friday plan. But when he woke up and checked his phone, Moderna was tanking and his position was down nearly $200,000. Quote from Togi, my port down $200K almost had me fully in a panic thinking maybe sell on the news was so obvious that they are selling days before the news. Originally, Togi had planned to flip his entire position from long to short on Friday, October 23rd, betting that Moderna stock would crash after the trial results were released on Saturday, but the sudden drop convinced him to move up his plans. Quote, I got too scared that the pump would happen so soon that I'd have no capital left to flip the port short come Friday. But so he sold his position at a loss, freeing up roughly $500,000 to bet against Moderna by buying put options ahead of the trial results. Perfect timing for Togi. Shortly after, the results were leaked and the stock crashed by 26%. In Togi's own words, quote, And the rest is some giga stroke of luck history. The news broke early somehow? Question mark, question mark, question mark, question mark. The most likely outcome for all traders would be that I was destined for rock-solid thesis blown up by some unlucky BS.
X says, that's my quant.
Lucky.
Giga stroke of luck.
Giga stroke of luck. Lucky my panic this morning got to my head enough to break my original game plan. In hindsight, this entire saga was beyond obvious. Thanks for playing. Not financial advice. I'm just learning and gambling.
Guy gets— has 2 dreams and a giga stroke of luck and says, in the end, this was all beyond obvious.
All beyond obvious, but also not financial advice. I'm just learning and gambling, but also put some respect on the thesis. S-U-M for some.
I don't know.
The thesis that started before he was aware of what the entire stock was riding on.
It's, it's, yeah, it's a very, very funny story. Anyway, yeah, Moderna, it's all over the place. How is Tyler doing this round?
So it's Nick playing now. Oh, it's Nick playing now.
Okay, we swapped. Let's see. So the score to beat is even.
Slightly negative.
If Nick—
if he can go even.
Yeah.
Okay.
Okay. I don't know if I played this map in the beta.
You look like you're about to pull up a—
Pretty good.
A shot from deep.
Is he leaning in yet? Stance forward for Modern Warfare 4? This is exciting. And somebody in the chat also said it's only 26 days until GTA 6, so it's, uh, Christmas is coming early for the next 62 days.
All right, Nick, get it together.
Get it together.
Okay, well, President Trump Says Sundar over at Google talked him out of renaming the Atlantic Ocean.
Okay.
Says, and I spoke to a brilliant guy, Sundar. He heads all of Google. He's a brilliant guy.
Okay.
Sergey and Sundar are totally brilliant guys. You know, they're still rattled from the Gulf. And I said, no, Sundar, I'm thinking of the Atlantic Ocean. Can you handle it? No, no, no. This time, I'm not doing it, he said. He said, oceans are different, sir. You know, They cover really a lot of countries. Please don't ask us to do that.
That's the craziest thing. So it would be the American Ocean? Is that the idea?
I think you would have to assume so.
Or Trump Ocean? Maybe Mar-a-Lago, the Ocean? I don't know.
I could see all of these.
I feel like there's enough in the Trump brand canon to rename everything. Because after you rename one golf, if you have another golf, You need to come up with another one. Well, uh, so you have America and then United States, the United States Ocean on the other side, I guess.
Yeah.
Try and make everything United States.
So apparently Lake Ontario only shows up as Lake America in the United States. Oh, geo-locked.
Oh, so that one went for sure.
I think it's the same for the Gulf too.
So now there's the lake, the Gulf, and then now there's—
We're really just living in our own little world.
It's a little bubble.
A little bit of a bubble.
Personalized AI. Intranet, basically. The American intranet. That's where we're going.
Let's check in with Joe Lonsdale. He was on CNBC yesterday.
Yeah, we got to break this one down.
And there's a lot to, to kind of process here.
Yes. This is Joe Lonsdale on CNBC. She calls it the trap bot for tradwife.
We have 6 little kids and it's telling us about our kids' health appointments and their activities.
Trying to figure out my 2-year-old how to deprecate his binky right now.
It's telling me when and when not to give it to him.
All right, pause. First off, he's calling the— I mean, well, let's start with the basics. He's calling in from a private aircraft.
Immediate alt.
Which is incredible. I think a lot of people— we actually have had guests this week call in from their planes, but they'll use a Zoom background.
Usually people do the Zoom background. Going no Zoom background, very strong play.
Second thought, you know, he's immediately— apparently in their household they're calling it the The Grok Bot. They've rebranded Grok Bot to Trad Bot.
Trad Wife Bot, yeah.
Trad Bot.
Yeah, so it unlocks the anchor with that.
Super— and we know Joe's contrarian, right? One of the ultimate contrarians, right? But going to Grok for parenting advice is probably the most— there's a lot of things that you could go to it for, but going to it for parenting advice is the ultimate contrarian move, knowing— Knowing what sort of hides in the weights, right? Knowing the thing that has emerged at times and could emerge at any moment.
At any moment, potentially.
That is maybe— may or may not be fully solved, right?
Sure, sure.
So knowing that, all things considered, very contrarian, but it makes me— knowing how often he's been contrarian and right, which has led to extreme investment results—
There's some wisdom here.
It makes me way more tempted to start going to Grok for parenting.
You might be looking at the next great parenting product.
Exactly. And maybe there's an opportunity here to reposition Grok around—
Maybe that's the key to product-market fit in that category.
Totally, totally. So he's running TradBot in the home for parent— just general household management parenting advice. I think that makes— again, it's contrarian, but I'm going to give it a shot now. Next up, language selection. We got to talk about language selection. He talks about, clearly one of their kids is using a binky. They want to get them off the binky. It's like a little addiction. Been there as a parent, but word selection, right? Deprecate the binky, right? Really, really good word selection, especially with this audience, right? This audience is an audience of capital allocators and this audience knows, okay, deprecate the binky. It clicks almost instantly.
Immediately.
Yeah. So all in all, 17 seconds on this video. One of the best performances we've seen of any CNBC hit in years. Yeah, the chat's saying just needs McDonald's and a Diet Coke. So if you really wanted to, to like get into that sort of like Donald mentality, you should have taken a bite or at least a sip or something. Yeah, but overall, round of applause. Fantastic. Yeah, fantastic.
Yeah, really elite.
Elite.
Not going to be— I'm going to go out on a limb and say I don't think it'll be topped.
I don't think it'll be topped. No, no, this is, this is S-tier performance.
S-tier. Uh, should we head over to one of Joe's, uh, portfolio founders?
Sure.
Friend of the show, Scott Wu.
What'd he say?
Uh, Scott Wu was doing some math.
Yes.
The math thing, obviously, once that got too easy, is then you take 8 cards and you make the current year. And this year is now 2025. Um, and so we get to try that one. And, um, in this case, it's actually quite, uh, quite easy because 13 minus 12 is 1, 11 minus 10 is 1, 1 plus 1 plus 7 is 9, and it turns out that 9 times 9 times 5 times 5 is exactly 25,000. Okay, well, but okay, so at some point that gets too easy.
Do you think he has to practice this? Because I know he's been elite at mental math and these, like, all these different types of math challenges from when he was a kid, but like, this can't come up on a daily basis in his job as CEO of Cognition, right? Or does it?
I think you should do it with potential hires.
Okay.
It's like, hey, let's go, let's talk for a couple hours and then let's block off 30 minutes for math tricks.
Yeah. I mean, he has that story about playing, what was it, high-stakes poker for a term sheet with Founders Fund?
Yeah, yeah. He was playing, I think, poker against Napoleon and chess versus Peter. Yeah, okay, okay. That was the one he wanted to do.
Okay. But yeah, I mean, you pull that trick out with like a A mid-tier VC who's trying to cram into a later round. Like, it's game over.
You get whatever price you want. I think this is a learned skill.
You think so?
Yeah.
OK, learn it.
All right.
OK, I want to see it.
In a month, I think I can do this on the show.
We've given you so many challenges. It's like learn the drums, prestige a cost.
Skydive without a parachute.
That one's doable with a net, right?
Didn't they tell us? No, you've got to do the Pastrana method.
What's the Pastrana method?
You have other people—
Oh, other people get you. OK, OK. I like that. I like that.
Let's head over to the Knicks.
Okay.
Let's check in with the Knicks.
What's going on with the Knicks?
The Knicks assistants were told they would receive championship rings eventually, but many longtime employees at Madison Square Garden, including including some who work in the Knicks business operations, will not receive rings at all, team sources told The Atlantic. Typically, most employees for NBA teams receive rings, even if they are not as fancy and expensive as the ones the players receive. Those MSG employees got their hopes up at the end of September when the Knicks sent an email to a long list of employees which gave recipients a first glimpse at their would-be championship rings. Atop the email, a copy of which The Athletic has obtained, was a graphic of 2 differently styled rings. Congratulations, your employee championship ring is here, the email read. This is one— this one is on the house. MSG is issuing a complimentary employee—
I didn't— I saw this and I didn't understand the full context.
Now I get it. MSG is issuing a complimentary employee championship ring. The same jeweler, the same craftsmanship, personalized with your name. No cost to you. There are 2 designs to choose from: Championship Gold and Garden Classic. Reserve the one you want below. But the email was a fake out, a phishing test Madison Square Garden sent to see if those employees would click. Multiple team sources said those who did click the link at the bottom of the message did not get to choose any jewelry. Instead, they were forced to attend a mandatory cybersecurity class to help satisfy some of Dolan's growing cybersecurity concerns. Those team sources said, definitely the most insane thing I've ever Heard of a company doing too.
I think it's a good plan. We got to start doing this. Send in Jackson, hey, we got you Nitro Circus tickets, click here. If he clicks it, he's got to go to cybersecurity training or just send me— Literally truck rally.
Figure out what every individual on the team, their hopes and dreams.
Yes.
Like it has to be something that, that is they literally have dreamed about for more than a decade.
Yes.
And then deliver that, deliver a phishing email based on that.
Yes.
And you could actually use AI to do that.
Yes, you could. You could. So I actually, I mean, I understand this is in very poor taste, but I don't have as much of a—
Meet and greet with Dale Earnhardt Jr.
I mean, I don't have as much of a problem with it if there is actually something about it that if you inspect the email thoroughly enough, you can tell it's a phishing email. So it has to come from MSG dot.
I don't have a problem. I don't have a problem with that.
But if it just comes from MSG, they have to get.
They're saying it's normal for all the employees to get rings. There's so these people not getting rings but getting the phishing email and having to go to the cybersecurity, you know, the the the naughty naughty meeting is completely insane.
Okay, I get that.
And demoralizing and. if you were one of these people, you work at MSG, you work for the Knicks, you won the championship. This probably will become the item in your life that is most significant to you.
Sure.
The thing that's irreplaceable.
Yes.
You've been hearing that, oh, maybe we're getting it, maybe we're getting it. And then you don't get it. And so you get the phishing email, you're just a little bit excited. So I can see cybercriminals Taking advantage of this kind of thing, it might even happen, right? Like, hey, when, when a team wins a championship, send a phishing email about rings to everybody involved and let's try to break into their systems that way. Sure.
If— look, it's a controversial decision not to give everyone the ring, but they made it crystal clear that in this organization, we just don't do it like the other teams. If you want to be on a team that gives rings to everyone, you got to go to a different team. Right. And they've made that crystal clear. And then so— and it's been publicized. So there's been news articles about, oh, Knicks employees don't get rings. And it's been established and the team has communicated that very clearly. And then there's a phishing email and it comes from— and it comes from IT set up a special domain. So if you looked at it closely, you could tell that it's a phishing email.
Still cruel.
Still cruel, but fair game.
This is cruel and unusual punishment.
Okay, well, we don't fully know how clearly they had communicated, at least I don't. And so with your series of events, if that's true, I do agree with you. I do agree with you. Given the level of cybersecurity threats, almost nothing is off the table for phishing. I think that CEOs should be hiring actors to put on full Hollywood makeup to go into the office as them and try and phish employees in person. I feel like you should— if you work at a company, you should see an actor who's dressed up like the boss knock on your door. Hey, can you, can you wire $10,000 to this account? And if they— and if they do it, boom, security training because you fell for the Nathan Fielder-esque phishing scheme.
In other news, Quest Diagnostics has been hacked. Patient data was exposed. They serve roughly half of U.S. hospitals and Physicians. The investigation is ongoing. Quest said yesterday, we have identified an incident involving unauthorized access to our Quantum Lab Service Manager, which certain clients use to place test orders, receive, and look up results. It's interesting they say certain clients. Like, you imagine, like, pretty much they probably have some other ways to check it. But like, this seems like they're kind of like the main thing. Upon discovery of the incident, we paused access to the system and we are continuing to investigate the incident. Our core business operations are not impacted and remain up and running. What data was affected? We believe some patient data within Quantum LSM was accessed, but other systems were not affected. We are working diligently to investigate the incident to determine the specific data affected. Does this mean patient health information or patient identifiable information was part of the unauthorized access? Yes.
Yes.
But we are still investigating to determine the specific So they probably have some cyber insurance policy that was inked like years ago. And so they'll probably have to pay out some sort of settlement or class action. But the financial motivation behind this one is curious. Like, I understand the botnets installing crypto miners, stealing crypto, stealing API tokens to work on large-scale distillation attacks, but you get a bunch of patient data. I'm wondering what the value of that is to a hacker other than just like you were trying to hack everything and why not this website too if it's running PHP or something.
But do you have any comments? Comments are saying like medical records of politicians in the wrong hands could give them leverage.
Yeah.
Blackmailing.
Testosterone results.
Extortion. Yeah, John would hate for his 4-digit testosterone To leak. Well, let's pull up this video from John. He recently me recently posted it. I'll send it over.
Cows know that humans exist. They can see us, but cows don't know that money exists. So just as cows can't understand the financial system that controls their lives today, we will not be able to understand. Understand the AI financial system that will control our lives in ten or twenty years, which means that we are the cows of the future. We are the cows of the future.
You got to be the wild bull.
The rider says, "My cows know money exists.
I do money spreads with them every morning." Can I read this article from the Wall Street Journal Mansion section, Jordi?
Hit me.
Alaska property comes with a helipad. This is a special, special property. 147 acres with a helipad. Guess how much it's going for? They're giving it away. Just $12.5 million. No, $12.5 million.
No, there's that house we saw in Alaska that was like Yeah, one of one.
I think it was on like five.
It was John John Lautner.
John Lautner.
But it was like six hundred K or something.
But this is a this is a very cool story. So Richard Strykin lived in Alaska his whole life. The sixty-eight-year-old retired commercial real estate developer was born in Fairbanks, spent time along the Bering Sea in an Eskimo village. But when it was time to settle down, he built a family compound. He chose Palmer, a small city about forty miles from Anchorage. Surrounded by glaciers, the landscape attracted him with its grandeur. His 147-acre property has views of the glaciers, mountain ranges, and Northern Lights. I climbed a tree and I saw the view potential, and that's where I decided I was going to build, he said. Now he's looking to downsize. Strykin has listed— has decided to list the compound for $12.5 million, making it one of the most expensive homes for sale in Alaska, according to Troy Dano of Faye Ranches. Strykin began to assemble his compound just outside the city limits in the '90s. On the property, which he calls the ultimate Alaska, he built a ranch-style single-story main bedroom— main house with 3 bedrooms, a garage, and a 2-bedroom apartment above it, and a helipad for his wife. He built vegetable gardens and an orchard. The couple's—
I thought you were saying he built the helipad for his wife. I was like, that's amazing.
That would be good. They have 13 grandchildren that live nearby. Let's give it up for that. During the winter solstice, Palmer receives only about 5 hours of sunlight a day. Stricken and his family spends this time skiing, visiting local winter festivals, and attending the grandchildren's indoor sporting events. When spring arrives, they shift to snowmobiling on the glaciers, prepping the orchard and gardens for the growing season, and enjoying outdoor community events. They are selling because he has built a lakefront home about an hour away, and his— and he and his wife plan to spend most of their time there. So, if you're in the market for a 147-acre Alaska compound, head over to—
You know who should consider?
Who?
Palmer Luckey.
Oh, yeah.
Ben Lamb.
Yeah.
They just set up a dog operation out there.
Why not there?
Ben Lamb and Palmer have Warhound.
Yeah.
Very exciting. Company coming out of stealth to genetically engineer dogs for military and law enforcement. Let's pull up this video of them talking about it back in 2023.
And I'm talking about biological weapons. I'm talking about using biology as a tool to solve a lot of military problems because we have new advanced bioengineering capabilities. So muscles that go in machines are going to be a really big deal. For example, building self-power scavenging robots that can live off of grass out in a field. Imagine if you could have radio relays that roam the plains and just eat grass, and that's how they power themselves. And they're very low signature. They can hide, they can hibernate. There's actually a lot of interesting biology-derived systems where you can take that stuff in, have bacteria in a little bioreactor that puts out methane gas, which you then run a fuel cell with. It's really, really cool stuff. And then of course, another big one is, you know, you guys are probably familiar with some of the companies out there doing de-extinction work of species. And I think there's a lot of species in the history of our planet where if we go back to the future, they're going to have excellent military applications. You think that German Shepherds, they weigh 150 pounds, are really good canine units. Well, what about dire wolves? What if you have 600-pound canine units carrying 150 pounds of armor? You're talking about something that weighs all up 8 times more with 100 times more bullet resistance. They're extinct now, but they don't have to continue to be. That sounds crazy, but I don't know if you guys know this, that the US military actually already has a lot of animals working in it. You have a lot of dogs working in the military. You have a lot of dolphins and seals that are working in the US Navy. And of course, we'd customize them a bit too, you know, give them some better endurance, give them The ability to breathe at high altitudes, things they didn't have when they were on the Arctic tundra. Imagine if you could have all of these survival characteristics of Arctic wolves, but with the obedience and trust and loving characteristics of domesticated animals. Of course, you can breed things like this over long periods of time with different levels of success, but what if you could really get it to be like every canine unit we have in the northern latitudes, they have the characteristics of The strongest Arctic wolf that ever walked the Earth. And also they love to cuddle and do exactly what I say.
I was always thinking that it would go the other direction. Instead of trying to scale up the friendly dog, you would try and make the fierce giant bear friendly and you would genetically engineer a domesticated bear and basically speed that up because dogs came from wolves over generations. They became friendlier. It feels like you could speed that up. But Palmer and Ben Lamb clearly know better than I do.
Why stop at You know, seals and dolphins, why not great friendly great white sharks?
Great white sharks with lasers on their backs.
Man's best friend in the seas.
That's right. Thank you for tuning in. Fantastic week, fantastic show. We made it through some sickness, some chaos.
We love you.
Let's get the Christmas countdown up again. 62 days to Christmas.
We'll see you Monday, actually.
Goodbye!
Goodbye!
More from Jordi


Moderna Drama, WSJ Mansion Section, Genetically Engineered Military Dogs | Thomas Wright, Kyle Schiller, Steven Schwartz


Elizabeth Holmes and Theranos, AI Data Center Forecast Jumps, Poppi’s Pepsi Deal | Diet TBPN


"You Can See Everything" Sparks Debate, 17% GDP Growth Please, Call of Duty Campaign Review | Katie Drummond, Bing Gordon, Daksh Gupta, Jean-Denis Greze, Quinten Farmer


We Review ‘You Can See Everything’, Tesla Unveils Rocket Powered-Roadster | Diet TBPN


"You Can See Everything" Review, Roadster Reactions, Eric Glyman Joins | Walter Isaacson, Christian Jensen, Tavarish


SELL EVERYTHING (Including Your Dollars), Tesla Roadster Hype, Valar Atomics VC Feud | Reed Albergotti, Bryan Cantrill, Daniel Kimminau


OpenAI Bugging Incident, Are Your Devices Listening? Xbox Launches Remix Lab | Diet TBPN


OpenAI Uncovers Spy Device, Apple x LG, Home Devices Tier List | Thomas Neckel, Kabir Jain, Danielle Axman, John Urschel, Nicolas Sharp, Jason Ballard, Erik Bernhardsson, Josh Tyrangiel, Aida Baradari


Muse Wonder, Social Reckoning Review, Apple HomeView | Eli Manning & Michael Waldron, Anjney Midha, William Chu & Negin Oliver, Neal Stephenson, Ravi Gupta & John Hegeman, Jack Goldburg, Oege de Moor, Nick Talken, Jeff Holden

